SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
A volcanic eruption may have catalyzed the plague's arrival in Europe, study suggests - 2Instructions to Amplify Certifiable Experience While Chasing after an Internet Advertising Degree
- 3Mossad unveils network of Hamas terror infrastructure across Europe
- 4Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
- 5Broken toilet, T-shirts on windows and collecting saliva: The weirdness of daily life aboard Orion
- Administrative building in Sharjah region targeted by Iranian drone, UAE authorities announce
- Israeli Chief of Staff declares new border with Gaza Strip
- Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed
- Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful!
- Where is Santa right now? NORAD tracks his 2025 Christmas Eve flight.
- Mussolini's summer villa on Adriatic coast sold for €1.2 million
- James Webb Space Telescope's mysterious 'little red dots' may be black holes in disguise
- Trump administration launches new immigration crackdowns in New Orleans and Minneapolis. Here are all the cities it has targeted so far.
- 23 Most Amusing Messages At any point Sent Among Kids and Their Folks
